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Abstract.  Protein import into the nucleus is a mul- 
tistep process that requires the activities of several 
cytosolic factors.  In this study we have purified a 
cytosolic factor that interacts with the nuclear pore 
complex glycoprotein p62.  Isolation involved biochem- 
ical complementation of cytosol depleted of this activ- 
ity by preadsorption with recombinant p62 and the use 
of a novel flow cytometry-based assay for quantitation 
of nuclear import.  The purified activity (NTF2) is an 
apparent dimer of "~14-kD  subunits and is present at 
'~106 copies per cell. We obtained a cDNA encoding 
NTF2 and showed that the recombinant protein re- 
stores transport activity to p62-pretreated cytosol. Our 
data suggest that NTF2 acts at a relatively late stage 
of nuclear protein import,  subsequent to the initial 
docking of nuclear import ligand at the nuclear enve- 
lope. NTF2 interacts with at least one additional cyto- 
solic transport activity, indicating that it could be part 
of a multicomponent system of cytosolic factors that 
assemble at the pore complex during nuclear import. 
M 
OLECULAR trafficking between the cytoplasm and 
nucleus occurs through large, proteinaceous struc- 
tures called nuclear pore complexes  (NPCs) ~ (re- 
viewed by Forbes,  1992;  Gerace,  1992;  Pante  and Aebi, 
1993;  Fabre and Hurt,  1994).  The NPC spans  the double 
membrane of the nuclear envelope and accommodates two 
mechanistically  different  types of transport:  passive diffu- 
sion and active transport.  Ions and other small  molecules 
passively diffuse through  ,,~10-nm aqueous channels  in the 
NPC.  Most macromolecules are too large to pass through 
these diifusional  channels  at significant rates and are trans- 
ported  through  a  central  gated  channel  in  an  ATP- and 
temperature-dependent manner. The information that targets 
a protein for nuclear import is referred to as a nuclear local- 
ization  sequence (NLS; Kalderon  et al.,  1984; Robbins et 
al.,  1991). NLSs are usually enriched  in basic residues, 
though they do not adhere to a consensus sequence. 
Although  the molecular basis for the active transport of 
proteins and RNAs through  the NPC is poorly understood, 
the emerging view of nuclear protein import is that of a mul- 
tistep process involving  interactions  between several cyto- 
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plasmic factors and the NPC (Forbes, 1992; Gerace, 1992; 
Goldfarb,  1992; Fabre and Hurt, 1994). The earliest step of 
nuclear protein import is thought to occur in the cytoplasm, 
where an NLS-containing protein binds to the NLS receptor 
(Adam and Gerace, 1991). The second step of  nuclear import 
occurs when the ligand-NLS receptor complex migrates  to 
the nuclear envelope and binds to the cytoplasmic surface of 
the NPC (Newmeyer and Forbes, 1988; Richardson et al., 
1988). This ligand-NLS receptor "docking" occurs in appar- 
ent association  with 30-50-nm long filaments that emanate 
from the cytoplasmic surface of the NPC (Richardson  et al., 
1988; Jarnik and Aebi, 1991). Subsequently, the ligand-NLS 
receptor complex is delivered to the central channel complex 
(discussed in Gerace, 1992). The final steps of nuclear pro- 
tein import involve gating of the central channel and translo- 
cation into the nucleus. 
Insights  into  the  biochemical  requirements  for  signal- 
mediated nuclear protein import have come from the use of 
cell-free  assays  involving  nuclei  that  are  assembled  or 
resealed with Xenopus egg extracts  in vitro (Newmeyer et 
al.,  1986),  or digitonin-permeabilized  tissue culture cells 
supplemented  with exogenous cytosol (Adam et al.,  1990). 
Studies with these systems have indicated that multiple cyto- 
solic factors are required for nuclear protein import (Adam 
et al.,  1990; Newmeyer and Forbes, 1990; Sterne-Marr et 
al., 1992; Moore and Blobel, 1992). One of these factors is 
a ~55-kD protein that specifically binds the NLS of SV40 
large T antigen (Adam and Gerace, 1991). Based on its func- 
tional properties and its subcellular localization,  the 55-kD 
protein was proposed to act as a transport carder that shut- 
ties between the cytoplasm and nucleus (Adam and Gerace, 
1991; Gerace, 1992). Nuclear protein import also appears to 
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depletion and reconstitution experiments using bacterially 
expressed Hsp70  (Shi and Thomas,  1992).  More recently, 
the Ras-related GTPase Ran/TC4 was identified as a nuclear 
transport  factor present  in Xenopus (Moore  and Blobel, 
1993) and mammalian (Melchior et al.,  1993) cytosol. Fi- 
nally, a 97-kD protein has been described that appears to play 
a role in NLS receptor-dependent ligand binding to the nu- 
clear envelope (Adam and Adam, 1994). 
Although progress has been made in isolating soluble nu- 
clear protein import factors, it has been technically difficult 
to demonstrate directly that polypeptides of  the NPC partici- 
pate in nucleocytoplasmic transport. The NPC, with a total 
mass  of  "~125  x  106  daltons,  is  estimated  to contain 
100-200 different  proteins. Only a small number of the NPC 
proteins have been identified (Fabre and Hurt, 1994). These 
include a group of eight 45-210-kD polypeptides that con- 
tain multiple copies of  O-linked N-acetylglucosamine. These 
polypeptides are  recognized by WGA  and certain  mAbs 
(Davis and Blobel, 1987; Snow et al., 1987).  At least some 
of these O-glycosylated proteins contain multiple copies of 
degenerate pentapeptide and/or tetrapeptide repeats (Fabre 
and Hurt,  1994). 
A transport-related function for these O-linked glycopro- 
teins was suggested by studies showing inhibition on nuclear 
transport by WGA (Finlay et al., 1987; Yoneda et al., 1987; 
Dabauvalle et al.,  1988;  Bataille et al.,  1990;  Dargemont 
and Kuhn, 1992) and anti-glycoprotein mAbs (Dabauvalle et 
al.,  1988; Featherstone et al., 1988; Bataille et al.,  1990). 
Additional evidence that NPC glycoproteins may be involved 
in nuclear import was obtained in studies using a Xenopus 
nuclear reconstitution extract. NPCs assembled in the ab- 
sence of  most WGA-binding proteins no longer supported the 
active transport of NLS-ligands (Finlay and Forbes, 1990). 
Using  a  different  approach,  our  laboratory  explored 
whether the family of NPC glycoproteins could interact sta- 
bly with essential cytosolic transport factors (Sterne-Marr et 
al.,  1992).  Pretreatment of cytosol with immobilized NPC 
glycoproteins resulted in the specific depletion of at least one 
factor required for nuclear protein import (Sterne-Marr et 
al., 1992).  This strongly suggested that one or more of the 
O-linked NPC glycoproteins plays a direct role in nuclear 
protein  import  via  interactions  with  cytosolic  transport 
factors. 
In this study we have identified a factor for nuclear protein 
import that interacts with the O-linked glycoprotein p62. We 
modified the nuclear protein import assay developed previ- 
ously in our laboratory (Adam et al.,  1990)  to include a 
rapid,  quantitative analysis by flow cytometry. HeLa cell 
cytosol preadsorbed with immobilized recombinant p62 is 
substantially inhibited in its ability to support nuclear pro- 
tein import when tested in the permeabilized cell assay. The 
activity that biochemically complements p62-preadsorbed 
cytosol was purified to near homogeneity from HeLa cell ex- 
tract.  The purified protein,  which we refer to as nuclear 
transport  factor  2  (NTF2),  elutes  from  a  gel  filtration 
column with an apparent mass of 28 kD and has a subunit 
molecular mass ~14 kD on SDS-PAGE.  After obtaining a 
cDNA for NTF2, we expressed the protein in Escherichia 
coli. Recombinant NTF2 fully restores transport activity to 
p62-pretreated  cytosol, indicating that NTF2  is  the only 
rate-limiting factor depleted under these conditions. We can- 
not detect a requirement for NTF2 in the docking of NLS 
ligand with the nuclear envelope, suggesting that NTF2 is in- 
volved in a subsequent transport event such as delivery to the 
central channel complex or translocation through the gated 
channel. 
Materials and Methods 
Preparation of Transport Ligand (FITC-BSA-NLS) 
Nuclear protein import was measured using digitonin-permeabilized tissue 
culture cells (Adam et al.,  1990;  Melchior et al.,  1993).  The transport 
ligand was fluorescently labeled BSA conjugated with synthetic peptides 
containing the SV40 large T antigen NLS (Kalderon et al., 1984). The con- 
jugate was prepared by first dissolving 10 mg of BSA (fatty acid free; Boeh- 
ringer Mannheim Biochemicals, Indianapolis, IN) in 1 ml of Na2HCO3, 
pH 9.0. To this was added 0.1 ml of 10 mg/ml FITC isomer I (Molecular 
Probes, Inc., Eugene, OR) prepared in DMSO. The mixture was stirred for 
60 min at room temperature, and the reaction was stopped by addition of 
0.1 mi of 1.5 M hydroxylamine. The unincorporated FITC was removed by 
gel filtration chromatography, and l-rag aliquots of  the FITC-BSA were fro- 
zen in liquid N2 and stored at  -80°C. 
Conjugation of NLS peptides to the FITC-BSA was performed using the 
heterobifunctional cross-linker sulfo-SMCC (Pierce, Rockford, IL). Each 
milligram of FITC-BSA was reacted with 50/tl of 20 mM sulfo-SMCC 
(made in DMSO) for 45 min at room temperature. The excess cross-linker 
was removed on a disposable Sephadex G-25 column (PD-10;  Pharmacia 
LKB Biotechnology Inc., Piscataway,  NJ). The conjugate was mixed with 
1 mg of NLS peptide (CGGGPKKKRKVED) overnight at 4°C. The unin- 
corporated peptide was removed either by gel filtration (Sephadex G-50) or 
by multiple washings on a  Centricon-30 filter (Amicon Corp., Danvers, 
MA). The FITC-BSA-NLS conjugate was frozen in liquid N2 and stored 
at -80°C until use. This ligand, which contains an average of 20 NLS pep- 
tides per molecule of BSA, was found distributed throughout the nucleus 
when viewed by fluorescence microscopy. Including twofold more cross- 
linker and consequently more NLS peptides per molecule of BSA produces 
a ligand that has a strong tendency to concentrate in the nucleolus. 
Nuclear Protein Import Assay 
Suspension  culture  HeLa  cells  were  propagated  in  Joklik's  modified 
S-MEM plus 10% FCS. To prepare cells for the transport assay, 50 ml of 
exponentially growing cells was harvested by centrifugation and washed 
once in ice-cold transport buffer (20 mM Hepes, pH 7.4,  containing 110 
mM potassium acetate, 2 mM magnesium acetate, and 0.5 mM EGTA). 
The cell pellet was resuspended to a total volume of 1 nd with transport 
buffer, and the cells were kept on ice. The cell concentration was determined 
by comparing the A55o of a  1:50 dilution of the washed cells with values 
from a standard curve. The cells were then diluted to 5  x  106 cells per ml 
using transport buffer containing 2 mM DTT and 1 ~g/ml each aprotinin, 
leupeptin, and pepstatin. After adding digitonin (from a  10%  stock in 
DMSO) to 0.01%, the cells were gently mixed by pipetting and held on ice 
for 6 rain. The cells were subsequently diluted with ice-cold transport buffer 
(containing DTT and protease inhibitors) to 50 ml and collected by centrifu- 
gation. The cell pellet was resuspanded in ~3 vol of transport buffer and 
stored on ice until use. The concentration of permeabilized cells in this 
preparation was ~5  ×  107/ml. 
Transport reactions (total volume of 40 ~1) contained HeLa cell cytosol 
(2-5 mg/ml), an ATP-regenerating system (1 mM ATE 5 mM creatine phos- 
phate, 20 U/rnl creatine phosphokinase), FITC-BSA-NLS (200-800 nM), 
and permeabilized HeLa cells (typically 5  x  105). The reactions were per- 
formed for 20 rain at 30oc in 6-ml polystyrene tubes (No. 2058;  Falcon 
Plastics, Cockeysville, MD) that fit the FACS  ~  instruments (Becton Dickin- 
son, Mountain View, CA). The transport reaction was stopped by transfer- 
ring the samples to an ice water bath. The cells were then diluted with 100 
vol (4 nil) of ice-cold transport buffer, collected by centrifugation,  and 
finally resuspended in ~0.3 ml of transport buffer. The fluorescence of 104 
cells was measured for each sample using the FACScan  °  flow cytometer 
(Becton Dickinson). The mean fluorescence per cell of each sample was 
then determined using Lysis II software (Becton Dickinson). Assays were 
not usually performed in duplicate, since the standard deviation for dupli- 
cates was typically '~2 %. The mean fiuorescence values between different 
experiments are not necessarily directly comparable, owing to potential 
variation in the extent of cell permeabilization and the use of different 
The Journal  of Cell Biology,  Volume 129, 1995  926 batches and amounts of NLS ligands. Note, however, that the data in Fig. 
4 A and Fig. 5 C, which show that recombinant NTF2 stimulates transport 
to the same extent as the HeLa cell protein, are from the same experiment. 
Preparation of HeLa Cell Cytosol 
16 liters of expunentially growing HeLa cells (,,o5  ×  105 cells per ml) was 
collected by centrifugation at 300 g for 10 rain. The cells were washed twice 
with ice-cold PBS and once with transport buffer containing 2 mM DTT. 
The washed cell pellet ('~40 ml) was resuspended in 2 vol of lysis buffer 
(5 mM Hepes, pH 7.4, containing 10 mM potassium acetate, 2 mM mag- 
nesium acetate, 1 mM EGTA, with 3/~g/ml each aprotinin, leupeptin, and 
pepstatin, 5 mM DTT, and 0.1 mM PMSF). After swelling for 10 rain on 
ice, the cells were disrupted with two to three strokes in a tight fitting stain- 
less steel homogenizer. Using this procedure, >95% of the cells were dis- 
rupted as judged by phase contrast microscopy. The homogenate was diluted 
with 0.1 vol of 10× transport buffer and centrifuged at 40,000 g for 30 rain 
at 4°C. The supernatant was filtered through four layers of cheesecloth and 
centrifuged at 150,000 g for 60 rain at 4°C. The resulting supernatant was 
aliquot°d, frozen in liquid N2, and stored at -800C.  Before use in trans- 
port reactions, cytosol was thawed, dialyzed against transport buffer con- 
taming 2 mM DTT, and stored as previously described. HeLa cell cytosol 
could be freeze thawed as many as three times without appreciable loss of 
protein import activity. 
Preparation of  p62 AjOinity-depleted Cytosol 
Bacterially expressed 1062 (see below) was dialyzed into 100 mM sodium 
bicarbonate, pH 8.3,  containing 100 mM NaCI and coupled overnight at 
4°C to CNBr-activated Sepharose beads (Pharmacia LKB Biotechnology 
Inc.) at a concentration of 3-5 mg/ml. The beads were quenched with 1 M 
ethanolamine for 2 h at room temperature,  washed five times in transport 
buffer, and treated for at least 1 h with 50 mg/ml BSA in transport buffer 
to  block  nonspecific binding.  Control  matrices,  which  did  not deplete 
cytosol of essential transport factors, were prepared in a similar manner. 
These included Sepharose beads coupled with BSA, total BL2 I(DE3)pLysS 
cell extract, or the putative coiled-coil domain of p62 spanning amino acids 
294-525. Small scale depletions were performed by combining cytosol with 
an equal volume of beads and mixing end over end for 30 min at 4°C. Large 
scale  depletions  used  a  10-ml  disposable  column  containing  2  ml  of 
p62-Sepharose. The column was treated with 4 ml of 100 mg/mi BSA fol- 
lowed by an 8-ml wash with transport buffer. HeLa cell cytosol (4 ml) was 
passed over the column three times, concentrated to 3 ml by vacuum dialy- 
sis, frozen in liquid N2,  and stored at  -800C. 
Purification of NTF2 
The rationale was to assay column fractions for an activity that would bio- 
chemically complement cytosol that was pretreated with p62-Sepharose. 
20 mi of HeLa cell cytosoi was thawed and centrifuged at 150,000 g for 
30 min at 4°C. The clarified supernatant was diluted 1:1 with 20 mM Hepes, 
pH  7.4,  and loaded  onto a  20-ml  DEAE-Sepharose  Fast  Flow  column 
(Pharmacia LKB Biotedmology, Inc.), previously equilibrated in the same 
buffer, at 45 mi/h. The column was washed with 60 mi of Tris-KCl buffer 
(20 mM Tris, pH 7.6, containing 50 mM KC1, 5 mM magnesium chloride, 
and 0.5 mM EDTA) and eluted with a 120-ml linear gradient of 50-300 mM 
KCI in Tris-KCI buffer.  100/~l of each fraction was dialyzed against trans- 
port buffer for 2 h (with one buffer change) in a microdialyzer unit (Pierce, 
Rockford, IL) that was previously blocked with 1% BSA. The DEAE, S100 
HR, and MonoQ activity profiles were generated by assaying 10/~l of each 
fraction in the presence of 15/zl of p62-treated cytosol using the permeabi- 
lized cell assay. 
DEAE fractions containing the NTF2 activity (eluting at ~175 mM KC1) 
were pooled, precipitated with solid ammonium sulfate (60% final concen- 
tration), resuspended with 1 mi of transport buffer, and clarified at 12,000 g 
for 15 min. The sample was applied to a gel filtration column (1.5  ×  65 
cm; SI00 HR; Pharmacia LKB Biotechnology Inc.) equilibrated in trans- 
port buffer and chromatographed at 15 ml/h. NTF2 activity, eluting with 
an apparent molecular mass of 28,000 daltons, was pooled, concentrated 
using a Centricon-30 filter, frozen in liquid N2, and stored at  -800C. 
FOr the final purification step, the pooled material from the SI00 column 
was fractiona~l on an FPLC MonoQ column (1 nil; Pharmacia LKB Bio- 
technology Inc.) using a flow rate of 0.5 mi/min and a linear gradient of 
transport buffer (buffer A) and transport buffer containing 1.0 M potassium 
acetate (buffer B). After loading the sample, the column was washed with 
buffer A for 5 rain followed by a  10-min linear gradient of 0-100% buffer 
B (in buffer A). We found that NTF2 reproducibly eluted at 32-33% buffer 
B  (400 mM potassium acetate).  In an effort to minimize the trace con- 
taminants whose elution overlapped slightly with NTF2 (see silver-stained 
gel of the column profile), we held the gradient at 32.8% buffer B for 3 rain, 
during which time the NTF2 eluted completely. The samples were dialyzed 
and assayed as previously described.  The active fractions were dialyzed 
against transport buffer containing 2  mM DTT,  frozen in liquid N2, and 
stored in aliquots at -80°C. 
Protein Sequencing 
The sequences of several peptides derived from NTF2 were determined by 
in situ tryptic digestion and standard Edman degradation methodology (Ae- 
bersold,  1989) by Dr.  John Leszyk at the Protein Chemistry Facility at 
the Worcester Foundation for Experimental Biology (Shrewsbury,  MA). 
Briefly, the peak fraction of NTF2 from a MonoQ profile was concentrated 
by centricon filtration, electrophoresed on a  16% pulyacrylamide gel, and 
transferred to Immobilon polyvinylidene difluoride membrane (Millipore 
Corp., Waters Chromatography, Milford, MA). The protein was visualized 
by Ponceau S staining, and the blot strip was excised and cleaved with tryp- 
sin. The resulting peptides were purified by HPLC on a Cls reversed-phase 
column. The peptides were sequenced on a 477A sequencer equipped with 
a model 120A in-line PTH analyzer (both from Applied Biosystems, Inc., 
Foster City, CA). 
Molecular Cloning and Expression of NTF2 and p62 
The sequences of the tryptic peptides indicated that NTF2 was identical to 
a previously cloned human protein of unknown function (Grundmaun et al., 
1988). Primers spanning bases 99-120 and 462--483 of the published cDNA 
were used to amplify the complete open reading frame by PCR from first- 
strand cDNA prepared from HeLa cell poly(A) RNA.  The PCR product 
was subcloned into pET23b, which was modified to include a stop codon 
at the HincII site, thereby eliminating translation of the histidine tag. The 
PCR-amplified open reading  frame  was  sequenced on both strands and 
found to correspond exactly to the published sequence. 
pET23b-NTF2 was transformed into JMI09 and BL21(DE3)pLysS cells, 
the latter of which gave better inducible expression.  Fresh transformants 
were grown in LB containing ampicillin and chloramphenicol overnight at 
37°C, collected by centrifugation, resuspended in fresh media, and diluted 
1:100 in LB containing ampicillin and chloramphenicol. Upon reaching an 
As0o  of  '~0.6,  expression  was  induced  with  0.4  mM  isopropyl  fl-a- 
thiogalactopyranoside for 2 h, at which time the bacteria were collected by 
centrifogation at 6,000 g for 15 rain at 4°C. The pellets were frozen in liquid 
N2 and stored at -80oc  until use. 
To isolate the recombinant NTF2, the cell pellet from a 500-ml culture 
was thawed in 20 mi of TNE buffer (50 mM Tris, pH 8.0,  100 mM NaC1, 
10 mM EDTA) containing 5/~g/ml each aprotinin, leupeptin, and pepstatin, 
0.5 mM PMSF, and 5 mM DTT. After five passes in a stainless steel ho- 
mogenizer, the viscous sample was centrifuged sequentially at 30000 and 
150,000 g. We note that though only 10-20 % of the NTF2 remained soluble 
under these preparative conditions, our attempts to recover active NTF2 
from the insoluble fraction have been unsuccessful. The supernatant from 
the high speed spin was stirred with solid ammonium sulfate (50% final con- 
centration) for 30 min at 4°C. The precipitate was collected by centrifuga- 
tion at 12,000 g  for 15 min, and the pellet was resuspended in transport 
buffer. After centrifugation at 12,000 g for 30 min, the clarified sample was 
chromatographed on an SI00 HR column (1.5  ×  65 cm) preequllibratnd in 
2×  transport buffer. 
Bacterial expression of rat p62 (Start et al., 1990) was performed essen- 
tially as described for NTF2, using a cDNA kindly provided by Dr. John 
Hanover (NIH, Bethesda, MD). The open reading frame was cloned into 
a modified pET23b that lacked the histidine tag (described above). The fro- 
zen bacterial pellet from a 500-ml culture was homogenized in 20 ml of 
TNE buffer containing protease inhibitors and 10 mM DTT. The homoge- 
nat° was then diluted to 100 mi and centrifuged at 12,000 g  for 15 rain. 
The resulting pellet was washed twice in the same manner. The washed in- 
clusion body fraction was then homogenized in 20 ml of TNE buffer con- 
talnlng 6 M urea, 0.1 M DTT, and 1 mM PMSF and incubated for 60 min 
on ice. The sample was clarified at 150,000 g for 60 min, and the resulting 
supernatant was dialyzed overnight against 100 vol of TNE buffer contain- 
ing 2 M urea and 20 mM DTT. Alternatively, the 6 M urea supernatant was 
rapidly diluted 1:2 with TNE, without noticeable protein precipitation. The 
2 M urea supernatant was dispensed in 4-mi aliquots and stored at -20oc 
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mated by SDS-PAGE and scanning densitometry. 
Immunological Reagents 
The relative levels of Ran/TC4, RCC1, and Hsp70 in cytosol pretreated with 
control or p62-Sepharose were compared by immunoblotting and detection 
by Enhanced Chemiluminescence (Amersham Corp., Arlington Heights, 
IL). Polyclonal antibodies to Ran/TC4 and RCC1 were kindly provided by 
Drs.  Peter  D'Eustachio  (NYU,  New  York)  and  Takeharu  Nishimoto 
(Kyushu University, Japan),  respectively. The anti-Hsp70 mAb was pur- 
chased from StressGen (Victoria, BC). 
The polyclonal antibody to NTF'2 was produced in mice using the amino- 
terminal  peptide  MGDKPIWEQIGS(C)  coupled  to  KLH.  Blots  were 
probed with serum diluted l:l,000, and detected by peroxidase-labeled sec- 
ondary antibodies and ECL. 
Quantitation of  Nuclear Envelope-Associated 
FITC-BSA-NLS (Docking Reaction) 
The effect of NTF2 on the targeting/binding of NLS ligand to the nuclear 
envelope (docking) was analyzed by depleting ATP from the assay and 
measuring the envelope-associated fluorescence. It should be noted that 
depletion of ATP from the assay resulted in variable levels of ligand as- 
sociated with the cytoplasmic compartment; therefore flow cytometry could 
not be used for this assay. We also noticed that docking was more readily 
observed using NLS ligands that were slightly overcoupled with NLS pep- 
tides. It was found that NLS conjugates of aliopbycocyanin and FITC-BSA 
that accumulated visibly in nucleoli were usually suitable for observing 
docking. In contrast, NLS conjugates that distributed uniformly throughout 
the nuclcoplasm, or were excluded from nuclcoli, did not seem to bind sta- 
bly to the nuclear envelopes of parmeabilized cells in the presence of crude 
cytosol. Interestingly, the "docking fraction" (described in the following sec- 
tion) promoted stable association of even low-coupled ligands with the nu- 
clear envelope. 
HeLa ceils were grown on  18-mm coverslips, washed with transport 
buffer, and perrneabilized with digitonin as previously described (Adam et 
al.,  1990).  The permeabilized cells were depleted of ATP by incubation 
with 16 U/mi hexokinase (H-5750; Sigma Chemical Co., St. Louis, MO), 
5 mM glucose, and 10 mg/rnl BSA in transport buffer for 10 min at 30°C 
in a  humid chamber. The components of the docking reaction included 
hexokinase,  glucose,  and  BSA  (same  concentrations  as  above),  plus 
p62-pretreated HeLa cell cytosol (2 mg/ml), NTF2 (20 #g/mi), and FITC- 
BSA-NLS (200 nM). The docking reaction was performed for 5  min at 
room temperature. The coverslips were washed three times in transport 
buffer (5 min each), fixed in 4% ultrapure formaldehyde (10 min), rinsed 
briefly in distilled water, and mounted in 10% glycerol in PBS (SlowFade; 
Molecular Probes Inc.). 
At least 12 fields per coverslip were photographed with a  15-s exposure 
using Tmax film (400 ASA; Eastman Kodak Co., Rochester, NY), and film 
was developed according to the manufacturer's instructions. The photo- 
graphic negatives were scanned with a UC1260 instrument (UMAX Data 
Systems Inc., Taiwan,  R.O.C.) at a resolution of 1,200 dpm, and the images 
were acquired and analyzed on a Macintosh Ilfx computer using the pro- 
gram NIH Image, version 1.55. NIH Image is public domain software writ- 
ten by Wayne Rasband at the NIH and is available through the Internet by 
anonymous ftp from zippy.nimh.nih.gov. 
The nuclear envelope fluorescence was measured at five different posi- 
tions per nucleus by densitometric scanning (4-pixel scan width). The mean 
maximum fluorescence  per nucleus (minus background) was determined for 
at least 20 cells from two coverslips. The fluorescence density profile taken 
across the nuclear envelope is essentially a symmetric peak. We take this 
as an indication that averaging the maximum fluorescence is an appropriate 
measure of relative ligand accumulation. 
Purification of  a HeLa Cell Docking Fraction 
A  modification of the procedure describing the purification of the NLS 
receptor and p97 from bovine cytosol (Adam and Adam,  1994) was used 
to prepare a fraction from HeLa cell cytosol that reconstitutes binding of 
NLS ligand to the nuclear envelope. HeLa cell cytosol (10 ml; prepared as 
previously described) was precipitated with ammonium sulfate (final con- 
centration, 50%) for 30 min at 4°C. The precipitate was collected by cen- 
trifugation and washed once in transport buffer containing 50% ammonium 
sulfate. The pellet was dissolved in 15 ml of buffer A (20 mM Tris, pH 8.0, 
containing 50 rnM NaCI, 5 mM MgCle, 0.5 mM EDTA, and 2 mM DTT 
and dialyzed overnight. After clarification (40,000 g for 30 min), the samph 
was applied to a 10-ml DEAE-Sepharose column equilibrated in buffer A 
The column was washed extensively with buffer B (same components a: 
buffer A, except containing 200 mM NaCI) and eluted with buffer C (saint 
components as buffer A, except containing 800 mM NaCI). The buffer I: 
eluate was bound to a 5-ml Hydroxylapatite column (preequilibrated in 
mM sodium phosphate, pH 7.0, containing 2 mM DTT), washed with 113 
column vol of preequilibration buffer, and eluted with 200 mM sodium 
phosphate, pH 7.0, containing 5 mM DTT. The fractions containing docking 
activity  (assayed using  digitonin-permeabilized monolayer HeLa  cells) 
were pooled, and BSA was added to a final concentration of 1%. The sample 
was concentrated twofold by dialysis in a collodion membrane against trans- 
port buffer containing 5 mM 13I'T. Aliquots were frozen in liquid N2 and 
stored at  -80°C. 
Results 
We developed a new method for rapid quantitation of signal- 
mediated nuclear protein import in vitro in a transport assay 
involving digitonin-permeabilized tissue culture cells sup- 
plemented with HeLa cell cytosol. The import substrate con- 
sisted of fluorescent BSA coupled with synthetic peptides 
representing the NLS of SV40 large T antigen (FITC-BSA- 
NLS). We found that nuclear protein import could be ac- 
curately quantitated by measuring the total cell-associated 
fluorescence using flow cytometry, as shown in Fig.  1 (left 
panels). 
At the end of a standard 20-min import reaction, an aver- 
age intensity of 754.79 fluorescence units per cell was mea- 
sured by flow cytometry (Fig. 1, Control, leflpanel).  Analy- 
sis of this sample by epifluorescence and phase microscopy 
(middle and left panels)  indicated that virtually all cell- 
associated FITC-BSA-NLS was within the nucleus. The sig- 
nal obtained with flow cytometry was strongly diminished by 
conditions that  inhibit  import both  in  vivo  and  in  vitro 
(reviewed by Forbes, 1992). Substantial inhibition of the ac- 
cumulation was observed (Fig. 1) if the assay was performed 
at 0°C (86.74 fluorescence units), in the presence of WGA 
(88.66 fluorescence units), or if the system was depleted of 
ATP  using  hexokinase  and  glucose  (134.58  fluorescence 
units). Correspondingly, fluorescence microscopy revealed 
the FITC-BSA-NLS was virtually absent from the nuclei of 
cold and WGA-blocked samples,  and only a  low level  of 
ligand was observed in the nuclei of cells depleted of ATP 
(Fig. 1, middle  panels). Moreover, the nuclear accumulation 
of NLS ligand measured by flow cytometry was inhibited 
85 % by including a 40-fold molar excess of NLS-containing 
histone H1 (Breeuwer and Goldfarb, 1990) in the transport 
assay (data not shown). 
Together, these controls established that flow cytometry is 
a  valid method for measuring nuclear protein  import in 
digitonin-permeabilized cells. This assay provides a much 
more rapid method for quantitating protein import than pre- 
viously described techniques. It should be a valuable tool for 
the biochemical characterization of nuclear protein import, 
including  the  identification of  novel  cytosolic  transport 
factors. 
Our laboratory has shown previously that preincubation of 
cytosol with the eight major O-linked glycoproteins of the 
NPC immobilized on Sepharose beads results in a loss of 
transport activity from the cytosol. This was apparently due 
to affinity depletion of an essential transport factor(s) that 
bound to certain of the NPC glycoproteins (Sterne-Marr et 
al.,  1992). We found that some of this factor depletion activ- 
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protein import by flow  cytom- 
etry and fluorescence micros- 
copy. Nuclear transport reac- 
tions were performed under 
standard conditions (control), 
or under conditions that in- 
hibit nuclear protein import in 
vivo and in vitro (O°C, WGA, 
or -ATP).  The fluorescence 
output generated by the flow 
cytometer is plotted as a histo- 
gram, with the mean fluores- 
cence of the bracketed region 
indicated (le~panels). A small 
aliquot of  each sample was ap- 
plied  to  a  polylysine-coated 
coverslip  and  photographed 
using epifluorescence  (middle 
panels) and phase microscopy 
(right panels).  The  samples 
were photographed  and printed 
at  the  same exposure. Bar, 
20 ~m. 
ity was associated with the "p62 complex" (data not shown), 
a stable complex containing four of the major NPC O-linked 
glycoproteins of 45, 54, 58, and 62 kD (Finlay et al.,  1991; 
Guan, T., and L. Gerace, unpublished data). We then tested 
whether recombinant p62 (Fig. 2 A) was itself sufficient for 
binding the putative  transport  factor(s)  when coupled to 
Sepharose  beads.  Cytosol  preincubated  with  Sepharose 
beads alone, or those coupled with BSA or total E. coli ex- 
tract, specifically lost no transport activity. However, the ac- 
tivity of cytosol preincubated with p62-Sepharose was in- 
hibited by 62 % (Fig. 2 B). In five experiments the inhibition 
was 65.4 +  7.3% (mean :k SD). To determine which region 
of the p62 polypeptide is responsible for binding the trans- 
port activity, we expressed the carboxy-terminal 232 amino 
acids of p62 and tested it as previously described. This do- 
main, which contains several regions predicted to form o~ he- 
lical coiled coils (Starr et al., 1990),  did not have detectable 
depletion activity (data not shown). We were unsuccessful 
in expressing a p62 fragment that contained residues 1-293 
and therefore can only infer that the factor-binding site most 
likely resides in this amino-terminal region. 
The transport activity depleted from cytosol using p62- 
Sepharose appeared to be distinct from several  previously 
characterized factors, as illustrated by the immunoblotting 
experiment shown in Fig. 2 C. Neither Ran/TC4 (Ren et al., 
1993)  nor  its  guanine nucleotide exchange factor,  RCC1 
(Ohtsubo et al.,  1987),  was depleted from cytosol by treat- 
ment with p62-Sepharose. Three cytosolic Ran/TC4 binding 
proteins (relative molecular masses of 27, 85, and 110 kD) 
detected by blot overlay with Ran-[3mP]GTP (Coutavas et 
al.,  1993) were also unchanged (data not shown). In addi- 
tion, the level of Hsp70 was unaffected  by this treatment (Fig. 
2 C). Fractionation of HeLa cell cytosol on a gel filtration 
column  revealed  that  the  complementing  activity  chro- 
matographed with an apparent molecular mass of 20-30 kD 
(see the following section). This was smaller than the NLS 
receptor (~50-60 kD; Adam and Gerace, 1991), and we set 
out to purify what appeared to be a novel transport activity. 
Purification of a Novel Factor That Complements 
Cytosol Pretreated with p62-Sepharose 
Attempts to elute the transport activity from p62-Sepharose 
using high salt, low pH, or concentrated MgCI2 were un- 
successful. Therefore, we decided to purify the factor from 
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Fold 
Specific  purifi- 
Fraction  Protein  Activity*  activity  cation Yield 
mg  U  Ulmg  % 
Cytosol  354  195,000  550  -  100 
DEAE-Sepharose  13.2  193,534  14,706  27  99 
S100 HR  0.63  117,459  186,442  13  61 
MonoQ  0.085  56,514  664,870  3.6  36 
* Activity  is the mean  nuclear  fluorescence  obtained  using a saturating  amount 
of  p62-treated  HeLa  cytosol  and a subsaturating  amount  of fractionated  cytosol 
minus the buffer  control. 
Figure 2. A novel cytosolic nuclear protein import factor interacts 
specifically with recombinant NPC protein 1062. (A) SDS-PAGE 
(8 % gel) of  the p62 protein used in these studies. (B) Affinity  deple- 
tion of a cytosolic transport factor using p62-Sepharose. HeLa cell 
cytosol was mixed with an equal volume of  BSA beads or p62 beads 
for 30 min at 4°C, and the unbound fractions were tested in the per- 
meabilized cell transport assay. The p62-pretreated cytosol was in- 
hibited by 62%.  (C) Immunoblot analysis (at three gel loadings) 
showing that the relative levels of cytosolic Ran/TC4, RCC1, and 
Hsp70 are unaffected by preincubation with p62-Sepharose. 
HeLa cell cytosol by conventional column chromatography, 
assaying for activity using biochemical complementation of 
cytosol  inactivated  by pretreatment  with  p62-Sepharose. 
The  assay  involved use  of a  saturating  concentration  of 
cytosol (usually ,o4 mg/ml) in order to avoid detecting ac- 
tivities that might stimulate transport simply because they 
were present at subsaturating levels. 
HeLa  cell  cytosol  was  loaded  on  a  DEAE-Sepharose 
column, washed extensively with buffer, and eluted using a 
linear salt gradient. A single peak of complementing activity 
was detected, eluting with ,o175 mM KC1, in fractions 11-14 
(Fig. 3 A, upper panel). The active fractions were pooled, 
precipitated with anunonium sulfate, and chromatographed 
on an S100 HR gel filtration column. The complementing ac- 
tivity eluted with an apparent molecular mass of 28 kD (Fig. 
3 A, middle panel). Fractions 47-51 were pooled, concen- 
trated,  and  applied  to  a  MonoQ column.  The maximum 
complementing activity that eluted from the MonoQ column 
was  found in fraction 18 (Fig.  3 A,  lower panel), exactly 
coincident with a low molecular mass (,,o14 kD) polypeptide 
detected by silver staining (Fig.  3 B). Starting with 20 ml 
(354 mg of protein) of HeLa cytosol, we obtained 85 #g of 
the factor, representing a 1,200-fold purification of the activ- 
ity (Table I). Based on its apparent role in nuclear transport 
and the fact that it is the second novel transport factor after 
the NLS receptor (Adam and Gerace, 1991) purified by our 
laboratory, we refer to this activity as NTF2, for Nuclear 
Transport Factor 2. 
The purified NTF2 was found to stimulate the nuclear pro- 
tein import of p62-pretreated cytosol in a saturable manner 
(Fig. 4 A), indicating that it is a rate-limiting component of 
the latter. NTF2 is the only rate-limiting factor removed un- 
der these experimental conditions,  as  illustrated by com- 
plementation with recombinant NTF2 (see Fig. 5). Maximal 
stimulation was observed at ,o3 #g/ml, corresponding to a 
concentration of ,o 200 nM. This is comparable to the con- 
centration of purified NLS receptor required for maximum 
import in permeabilized cells (182 nM; Adam and Gerace, 
1991). It is significantly less, however, than the concentration 
of Hsp70 reported to be necessary to restore full transport 
activity to HeLa cell cytosol that had been pretreated with 
reagents to deplete heat shock proteins (2.9 #M;  Shi and 
Thomas, 1992). We note that like the NLS receptor (Adam 
and Gerace, 1991), NTF2 is capable of stimulating several- 
fold the transport activity of  dilute cytosol, though NTF2 has 
little effect  when assayed in the presence of saturating cytosol 
(data not shown). 
Since the affinity depletion scheme involved exposing p62 
beads  to crude cytosol,  it was  formally possible that the 
p62-NTF2 interaction was indirect, perhaps mediated by an 
additional  cytosolic  factor.  We  therefore  tested  whether 
NTF2 would bind directly to p62 immobilized on Sepharose 
beads. Purified NTF2 was incubated with BSA-Sepharose or 
p62-Sepharose,  and the unbound fraction of each sample 
was tested for its ability to complement p62-treated cytosol. 
We observed substantial depletion of NTF2 activity in the 
sample treated with p62-Sepharose as compared with con- 
trol Sepharose (Fig. 4 B). These data indicate a direct inter- 
action between the NPC protein p62 and the cytosolic trans- 
port factor NTF2 and provide strong evidence for a direct 
role of p62 in nuclear protein import. Moreover, our data in- 
dicate that NTF2 is depleted rather than simply inactivated 
by recombinant p62, as also illustrated by immunodetection 
experiments (see Fig.  7  C). 
Molecular IdenU'fication and Expression of 
Recombinant NTF2 
To determine the primary structure of NTF2, several tryptic 
peptides derived from the purified "ol4-kD band were ana- 
lyzed  by  microsequencing  (Table  II).  A  search  of  the 
GenEMBL data base revealed that the sequence of each of 
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cell cytosol. (A) Increasing concentrations of NTF2 were added to 
transport reactions that contained a saturating amount of cytosol 
pretreated with p62-Sepharose. The extent of nuclear protein im- 
port was saturated  in the presence of 200 nM exogenous NTF2. 
This compares favorably with the predicted final concentration of 
cytosolic NTF2 in transport assays using control cytosol, which 
based on our purification yield is  ,~130  riM.  (B) Interaction of 
NTF2 with p62 in vitro. Purified NTF2 was diluted with 1 mg/ml 
BSA and incubated with BSA beads (NTF2/control beads) or p62 
beads (NTF21p62 beads) for 30 min at 4°C, and the unbound frac- 
tion was tested for its ability to complement HeLa cytosol that itself 
was pretreated with p62 beads. 
Figure 3. Purification ofa cytosolic factor that restores nuclear pro- 
tein import activity to cytosol that has been pretreated with p62- 
Sepharose. (A) Activity profiles from the sequential DEAE-Seph- 
arose, S100 HR, and MonoQ columns used to purify NTF2. The 
activity profiles were generated by assaying 10 #I of each column 
fraction in the presence of p62-treated cytosol (see Materials and 
Methods).  No  activity  was  detected  in  the  flow-through of the 
DEAE-Sepharose column (data not shown), indicating that NTF2 
is the only complementing activity present in HeLa cytosol.  (B) 
Silver-stained SDS-polyacrylamide gel (16 %) of selected fractions 
the six tryptic peptides was contained within the open read- 
ing frame of a cDNA encoding a  127-residue human protein 
of unknown function (Grundmarm et al.,  1988). The peptide 
sequences matched the human protein sequence at 52 of 53 
positions.  The single indeterminate residue in peptide 5 is a 
cysteine, a residue that would not have been revealed by our 
analysis. 
We designed PCR primers based on the published nucleo- 
tide sequence (Grundmann et al.,  1988) in order to clone the 
open  reading  frame  of  NTF2.  Using  first-strand  cDNA 
generated from HeLa cell poly(A) RNA as the template, we 
amplified the open  reading  frame and  determined  that the 
from the  MonoQ profile. The peak of protein detected by silver 
staining (fraction 18) coincides with the peak of protein import ac- 
tivity measured with the permeabilized cell transport assay. 
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Derived  from Purified NTF2 
Amino acid position 
Peptide sequence  in human p14 
LSSLPFQK  56-63 
IQHSITAQ  64-71 
ADEDPIMGFHQ(M)(F)(L)  91-104 
ADEDPIMGFHQMFLLK  91-106 
NIN(D)AWVXTN(D)MFR  107-120 
LALHNFG  121-127 
resulting product contained a nucleotide sequence that was 
identical to that of  the published human sequence. NTF2 was 
expressed in E. coli, and the soluble fraction obtained after 
isopropyl/~-D-thiogalactopyranoside induction was purified 
by ammonium sulfate precipitation and gel filtration chro- 
matography (Fig. 5 A). The recombinant NTF2, when added 
to cytosol that had been pretreated with p62-Sepharose, re- 
stored transport to near control levels (Fig. 5 B). The maxi- 
mum level of transport observed with recombinant NTF2 
was comparable to that obtained with the purified human 
protein (Fig.  4  A  and Fig.  5  C).  Approximately threefold 
more recombinant protein was required to achieve saturation 
('~600 nM), which is probably attributable to the presence 
of inactive NTF2 in the preparation. 
We tested whether NTF2, like the NLS receptor (Adam 
and Gerace, 1991) and p97 (Adam and Adam, 1994), is sen- 
sitive  to  sulfhydryl  modification.  Pretreatment  of recom- 
binant NTF2 with 5 mM N-ethylmaleimide (NEM)  for 30 
min at room temperature did not affect its ability to comple- 
ment p62-treated cytosol (Fig. 5 D). This is consistent with 
previous data from our laboratory showing that an NEM- 
insensitive transport factor is depleted from cytosol by im- 
mobilized O-linked glycoproteins (Sterne-Marr et al.,  1992). 
Using  an  affinity depletion  approach  analogous  to  that 
used with p62,  we tested whether Sepharose-immobilized 
NTF2 could interact with other cytosolic nuclear protein im- 
port factors. Substantial depletion of transport activity was, 
in fact, observed when HeLa cell cytosol was pretreated with 
NTF2-Sepharose (Fig. 5 E, stippled bars).  Since NTF2 ap- 
Figure 5. Characterization  of the recombinant NTF2 protein.  (A) Electrophoretic analysis (16% gel) of the NTF2 purified from bacterial 
lysate. (B) Addition of recombinant NTF2 to p62-pretreated  cytosol restores transport  to near control levels. Transport was measured 
in control cytosol, p62-pretreated cytosol, and p62-pretreated cytosol supplemented with 1.6/~g of NTF'2. (C) Titration of the recombinant 
protein in the permeabilized cell assay. Recombinant NTF2 stimulates transport to about the same maximal level as the purified HeLa 
cell protein (compare with Fig. 4 A). (D) NTF2 is a NEM-insensitive transport factor. Recombinant NTF2 was treated with 5 mM NEM, 
quenched with excess DTT, and assayed for its ability to complement transport  using p62-pretreated  cytosol.  (E) NTF2 interacts with 
an essential cytosolic transport  factor. Recombinant NTF2 was coupled to Sepharose beads and incubated with HeLa cell cytosol,  and 
the unbound fraction was tested in the transport assay. The substantial transport inhibition observed (,070%)  indicates that NTF2 is likely 
to interact with an additional cytosolic factor required for nuclear protein import. 
The Journal of Cell Biology, Volume 129, 1995  932 pears to dimerize (Fig.  3 A and Grundmann et al.,  1988), 
we considered the possibility that the reduction of transport 
activity  could  be  due  to  cytosolic NTF2  binding  to  the 
Sepharose-immobilized NTF2.  Supplementing the control 
and  NTF2-treated cytosols with  recombinant protein  re- 
suited in only a modest increase in transport (Fig. 5 E, solid 
bars). Together, these data suggest that NTF2 interacts with 
at least one additional cytosolic transport factor that can be 
made rate limiting in our assay.  This suggests that NTF2 
could be part of a multicomponent system of cytosolic fac- 
tors assembled at the NPC during nuclear protein import. 
NTF2 Appears to Be Required  for a Late Step of 
Nuclear Protein Import 
It has been shown previously that targeting of NLS ligands 
to the NPC (docking) and subsequent translocation through 
the nuclear pore require different cytosolic factors (Moore 
and Blobel,  1992). The docking reaction can be examined 
as a distinct transport step by depleting ATP from the trans- 
port assay and measuring the accumulation of FITC-BSA- 
NLS at the nuclear envelope. The level of cytoplasmic back- 
ground in this assay (Fig. 6 C) made it necessary to measure 
nuclear envelope-associated fluorescence by densitometric 
scanning. To test whether NTF2 is involved in the initial tar- 
geting of NLS ligands to the NPC,  we compared levels of 
transport and ligand docking in assays containing p62-pre- 
treated  cytosol  without  or  with  addition  of recombinant 
NTF2. The level of transport, measured in an ATP-contain- 
ing assay,  was  stimulated 3.5-fold when cytosol was com- 
plemented with recombinant NTF2 (Fig. 6 A). By contrast, 
the level of  docking, measured in an ATP-depleted assay, was 
not significantly changed by addition of NTF2 (Fig. 6 B). 
This suggests that NTF2 functions in a  step subsequent to 
the "ATP-independent" association of NLS ligand with the 
nuclear envelope. 
Nuclear Protein Import Requires NTF2, Ran/TC4, 
and a Docking Fraction 
We sought to obtain additional evidence that NTF2 is re- 
quired for nuclear protein import and, more specifically, to 
test further whether NTF2 is required for binding of NLS 
substrate to the nuclear envelope. To this end, we reconsti- 
tuted protein import in permeabilized cells using NTF2 and 
the small GTPase Ran/TC4 (Melchior et al.,  1993; Moore 
and  Blobel,  1993)  prepared as  recombinant proteins,  to- 
gether with a cytosolic fraction that reconstitutes docking of 
NLS  ligand  to  the  nuclear envelope (Moore and  Blobel, 
1992; Adam and Adam,  1994). The addition of any one of 
these components to the permeabilized cell assay resulted in 
only low levels of import (Fig. 7 A). Addition of the docking 
fraction and NTF2, or docking fraction and Ran/TC4, also 
resulted in only a low level of transport, whereas an inter- 
mediate  level  of transport  was  obtained  with  NTF2  and 
Ran/TC4. However, the presence of all three factors resulted 
in a level of transport that was significantly higher than the 
sum of the levels supported by the individual components. 
Notably, adding Ran/TC4 to NTF2 and the docking fraction 
stimulated transport by more than fourfold. The data from 
this experiment indicate that NTF2 and Ran/TC4, as well as 
the docking fraction, perform distinct functions in nuclear 
protein import. Furthermore, the apparent synergy observed 
Figure 6. Analysis of the stage of nuclear protein import that re- 
quires NTF2. (A) Addition of recombinant NTF2 to p62-pretreated 
cytosol  stimulates nuclear  protein  import  3.5-fold in digitonin- 
permeabilized cells in a 20-min assay. (B) NTF2 does not stimulate 
the association of FITC-BSA-NLS with the nuclear envelope in a 
5-min docking reaction.  Similar results were obtained when the 
docking reaction was performed for 20 min (data not shown). (C) 
Examples of  docking mediated by p62-pretreated cytosol, recorded 
by confocal microscopy. The cytoplasmic background is due in part 
to the use of a highly coupled NLS ligand. The details of the dock- 
ing assay are described in Materials and Methods. 
between these components is consistent with, but does not 
prove, that these factors act in a common transport pathway. 
The docking fraction used in these experiments was found 
to be sufficient for binding NLS ligand to the nuclear enve- 
lope in a punctate pattern (Fig. 7 B), indicating that this frac- 
tion likely contains the NLS receptor and p97 (Adam and 
Adam,  1994). Immunoblot analysis of the docking fraction 
with an antibody raised against an amino-terminal peptide of 
NTF2 showed that it was devoid of detectable NTF2 (Fig. 
7  C).  These results provide further evidence that cytosolic 
NTF2 is not required for the initial binding of NLS ligand 
at the nuclear envelope and suggest that it acts subsequent 
to the docking step. 
Discussion 
We  have  developed  a  flow  cytometry-based method  for 
measuring nuclear protein import in permeabilized cells and 
used this method to isolate a novel cytosolic transport factor. 
This factor, which we refer to as NTF2, was purified from 
HeLa cell extract based on its ability to complement bio- 
chemically cytosol that was affinity depleted with NPC pro- 
tein p62. Recombinant NTF2 restores transport activity to 
p62-pretreated cytosol to the same extent as the native HeLa 
cell protein, thus establishing that the complementing activ- 
ity can be ascribed to NTF2 itself and not a copurifying spe- 
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binant proteins and a HeLa cell docking fraction. (A) The levels of 
transport  supported by NTF2, Ran/TC4, and the docking fraction 
alone and in combination were tested. Saturating concentrations of 
NTF2 and Ran/TO4 were used; however, no attempt was made to 
use a saturating concentration of  the docking fraction. Note that the 
level of transport supported by control cytosol was 400 units (data 
not shown), and the cell-associated fluorescence occurring  in the 
absence  of added  factors  (95  units)  was  subtracted  from each 
sample. (B) Fluorescence  micrograph of digitonin-permeabilized 
HeLa cells incubated with the HeLa cell docking fraction and a 
low-coupled NLS ligand on ice for 25 min. Docking was also ob- 
served at room temperature in the presence of I mM ATP, though 
a low level of transport was also apparent in a subset of cells (data 
not shown). (C) Immunoblot analysis of the components used in 
cies. Our data suggest that NTF2 interacts directly with NPC 
protein 1362 and exerts its effect at a relatively late step in the 
nuclear protein import pathway. 
Interestingly, data base comparisons suggested the exis- 
tence of NTF2-related proteins in phylogenetically diverse 
species. Human NTF2 is 46, 33, and 36% identical to partial 
open reading frames cloned in yeast (Saccharomyces cere- 
visiae), Arabidopsis,  and rice, respectively (Fig. 8). Particu- 
larly  striking  is  a  highly  conserved  central  region  corre- 
sponding to residues  14-79 in the human protein in which 
the degree of identity to the human protein is 47-53%. The 
sequences of the amino- and carboxy-terminal regions of the 
four proteins are less well conserved. Given the significant 
sequence relationships that span three kingdoms, we antici- 
pate that NTF2 will prove to be a highly conserved compo- 
nent of the nuclear transport apparatus. 
Functional Involvement of O-linked Glycoproteins 
in Transport 
Previous studies have suggested a potential role for the group 
of eight O-linked NPC glycoproteins in nuclear protein im- 
port (see Introduction). Data from our laboratory indicated 
that at least two of these polypeptides can interact with essen- 
tial cytosolic transport factors (Sterne-Mart et al.,  1992). 
Here we have shown that NPC protein p62, prepared as a 
recombinant polypeptide, alone is sufficient to deplete HeLa 
cell cytosol of an essential transport factor. This suggests a 
direct role for 1362 in nuclear import, and indicates that the 
multiple  copies  of N-acetylglucosamine found on  the  na- 
tive protein  (Holt  et  al.,  1987)  are  not  essential  for  the 
p62-NTF2  interaction.  Whether  the  45-,  54-,  and  58-kD 
subunits of the p62 complex play a role in regulating this in- 
teraction  or  whether  these  subunits  also  interact  directly 
with NTF2 will require further investigation. 
Our data point to the amino-terminal domain of p62 as the 
site of interaction with NTF2.  This region is predicted to 
form a B sheet structure and contains multiple copies of a 
degenerate  pentapeptide  repeat  related  to  the  sequence 
GFXFG (Starr et al., 1990; Hanover, 1992). The hydropho- 
bic nature of the repeats suggests that they might help form 
the core of a B strand, with the intervening sequences con- 
stituting the loop structures.  This type of repeat is found in 
a  number  of phylogenetically  diverse  NPC  polypeptides 
(Fabre and  Hurt,  1994),  implying a  potentially important 
role  in  NPC  function.  Surprisingly,  deletion  studies  have 
failed to reveal an essential function for the repeat domains 
in the NSP1 (Nehrbass et al.,  1990) and NUP2 (Loeb et al., 
1993), proteins of S. cerevisiae, though this "lack of pheno- 
type" should be interpreted with caution. Since multiple pro- 
these studies using an antibody to the amino terminus of NTF2. A 
major reactive band was detected  in HeLa cytosol  (lane 1) that 
comigrates with purified NTF2 (lane 5). The minor, more slowly 
migrating immunoreactive species in lane I probably corresponds 
to NTF2, as we have noticed that some preparations of NTF2 re- 
solve as a doublet (see Fig. 3 B). NTF2 was not detected in p62- 
pretreated cytosol (lane 2) or in the docking fraction (lane 3). The 
recombinant NTF2 (lane 4) contains a 12-amino acid addition at 
the amino terminus,  causing it to migrate  more slowly than the 
HeLa cell protein (lane 5). 




lqgure 8. Alignment of human NTF2 with related 
open reading frames identified in yeast (S. cere- 
visiae), Arabidopsis, and rice. Amino acids that 
are identical to the human sequence are shown in  Human 
reversed type. The percent identities (s¢¢  Discus-  Yeast 
sion) were determined using the GCG program  Arabldopsls 
BESTFIT with the default settings. The yeast se- 
quence was translated from the antisense strand of  Rice 
the 5' noncoding region of the PSL1 gene. Since 
there is no in-frame stop codon, the sequence is  Human 
likely to extend beyond the carboxy-terminal  me-  yeast 
thionine that corresponds to residue 84 in human  Arabldopsis 
NTF2. The GenEMBL  accession  numbers for these  Rice 
sequences are as follows: human, X07315; yeast, 
L22204; Arabidopsis, "1"04451; rice, D23112.  Ruman 
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teins of each NPC contain these types of repeats (Fabre and 
Hurt, 1994), they may fulfill redundant functions. It will be 
important to  determine  whether  NTF2  interacts  directly 
with the conserved pentapeptide repeats of p62, or with the 
nonconserved sequences interspersed between these repeats. 
If NTF2  associates  with  the  pentapeptide  repeats  them- 
selves,  it is possible that this protein interacts with other 
components of the NPC containing pentapeptide repeats in 
addition to p62,  such as  Nup153  (Sukegawa  and Blobel, 
1993) and CAN (Kraemer et al.,  1994).  In this regard, we 
note that the cytosolic transport activity bound by nup153 
(referred to as pla0; Sterne-Marr et al., 1992) and NTF2 are 
both insensitive to alkylation by NEM. 
NTF2 Function in Nuclear Protein Import 
Our data suggest that NTF2 acts at a step distal to the initial 
binding of NLS ligand to the NPC.  We have shown that 
efficient binding of NLS ligand to the nuclear envelope can 
be reconstituted with either p62-pretreated cytosol or a par- 
tially purified docking fraction. Both of these samples are 
devoid of immunologically detectable NTF2.  Addition of 
NTF2 to either p62-pretreated cytosol or the docking frac- 
tion and Ran/TC4 stimulates transport approximately three- 
fold but does not stimulate docking (examined in the case of 
p62-pretreated cytosol). The likelihood that NTF2 acts sub- 
sequent to docking is further supported by immunoelectron 
microscopy showing that p62  is  located near the central 
channel complex, but not at the more peripheral cytoplasmic 
fibrils implicated in ligand docking (Guan, T., and L. Ger- 
ace, unpublished data). 
After the original submission of this work,  Moore and 
Blobel (1994) reported the identification of a low molecular 
weight transport factor in Xenopus  cytosol that, based on 
peptide sequence, is likely to be the amphibian homologue 
of NTF2.  It was shown that the Xenopus protein together 
with Ran/TC4 promoted the dissociation of NLS ligand from 
the nuclear envelope, supporting a role for NTF2 in a late 
step of transport. These observations are consistent with our 
quantitative analysis showing that NTF2 does not stimulate 
the binding of NLS ligand to the nuclear envelope. The low 
molecular weight Xenopus activity was also reported to co- 
elute from a gel filtration column with a fraction of Ran/TC4 
(Moore and Blobel,  1994),  though whether these proteins 
directly interact remains to be established. We have found 
no evidence for association of Ran/TC4 with NTF2 by gel 
filtration of HeLa cell cytosol (Melchior et al.,  1993) and 
have been  unable  to  detect  either  GTPase  activating or 
nucleotide exchange activity of NTF2 for Ran/TC4 (Paschal, 
B. M., E  Melchior, and L. Gerace, unpublished observa- 
tions). 
The maximum of 70%  transport inhibition observed in 
p62-pretreated cytosol presumably reflects residual NTF2 in 
the permeabilized cell fraction. However,  at this point we 
cannot formally rule out that NTF2 is a stimulatory rather 
than  essential  transport  factor.  This  question  should  be 
resolved when transport-inhibiting anti-NTF2 antibodies be- 
come available. 
Given the caveat that permeabilized cells seem to contain 
residual levels  of cytosolic transport factors,  it has been 
shown that re,  constitution of NLS ligand binding to the nu- 
clear envelope requires the addition of only two exogenous 
cytosolic factors: the 55-kD NLS receptor (Adam and Ger- 
ace,  1991) and p97 (Adam and Adam, 1994).  By contrast, 
other data have suggested that the Xenopus NLS receptor 
(importin) alone mediates this binding step (Gorlich et al., 
1994). The discrepancy is likely related to the 50-fold higher 
concentration of the Xenopus NLS receptor used in the latter 
study (Gorlich et al., 1994) as compared with the study using 
mammalian NLS receptor and p97 (Adam and Adam, 1994). 
Furthermore,  the "complete" nuclear protein import  sup- 
ported by saturating levels of importin and Ran/TC4 is 30% 
of the  transport  supported  by Xenopus  cytosol (Table  I; 
Gorlich et al., 1994). These data support the view that addi- 
tional cytosolic factors, including p97  (Adam and Adam, 
1994) and NTF2 (this study and Moore and Blobel, 1994), 
are required to reconstitute protein import fully. 
Up to now, five distinct cytosolic transport factors have 
been identified: NLS receptor  (Adam and Gerace,  1991; 
Gorlich  et  al.,  1994),  Hsp70  (Shi  and  Thomas,  1992), 
Ran/TC4 (Moore and Blobel, 1993; Melchior et al., 1993), 
p97  (Adam and Adam,  1994),  and NTF2  (this study and 
Moore and Blobel, 1994). As a group, these factors facilitate 
multiple transport steps, a view supported by our observa- 
tion that significant nuclear import occurs only when a cyto- 
solic fraction that mediates NLS ligand docking at the nu- 
clear envelope is combined with Ran/TC4 and NTF2. 
Our finding that NTF2 itself can deplete/inactivate at least 
one additional transport activity from cytosol suggests that 
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tors that interact with p62 in the transport cycle. A number 
of different  functional roles can be envisaged for NTF2 in 
this context. In one scheme, NTF2 could serve as an adaptor 
molecule that mediates or regulates the hypothetical interac- 
tion between the ligand-NLS receptor complex and 1362. Al- 
ternatively,  it could promote structural  changes in the p62 
complex related to either ligand delivery to the central chan- 
nel complex or gating of the central channel. The high cyto- 
solic concentration of NTF2 and the fact that similar concen- 
trations  of NTF2  and  the  NLS  receptor are  required  for 
maximum  transport  in permeabilized  cells  are  consistent 
with NTF2 acting as a stoichiometric rather than regulatory 
component of the transport  machinery. 
It is interesting  to note that p62 is symmetrically localized 
on both the cytoplasmic and nucleoplasmic sides of the NPC 
(Cordes et al., 1991; Guan, T., and L. Gerace, unpublished 
observations).  This  could  suggest  functions  for  putative 
NTF2-p62 interactions on both surfaces of the NPC during 
the nuclear import cycle. Alternatively,  the symmetrical dis- 
tribution of p62 could imply that NTF2 functions in nuclear 
protein export as well. One could imagine that the process 
of nuclear protein export is mechanistically  similar to nu- 
clear protein import, with initial binding of a transport com- 
plex to the peripheral nucleoplasmic filaments followed by 
interactions  with the  central  channel  complex  containing 
p62. Although our data strongly argue that NTF2 interacts 
with p62 during the nuclear import process, we wish to point 
out  that  an  unequivocal  demonstration  of this  point  will 
probably  require  arresting  transport  intermediates  in vivo 
followed by cross-linking and immunoprecipitation. 
In conclusion, we have identified NTF2 as a novel cyto- 
solic factor for nuclear protein import that interacts  with 
NPC protein p62.  Our evidence suggests that NTF2 func- 
tions after the initial docking of NLS ligand with the NPC 
and that it may be part of a multicomponent system of cyto- 
solic factors assembled at the NPC during the transport cy- 
cle. These findings support the emerging view that nuclear 
protein import is a cooperative effort between multiple solu- 
ble factors and the NPC. 
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